UY36396A - Síntesis de copanlisib y su sal diclorhidrato - Google Patents
Síntesis de copanlisib y su sal diclorhidratoInfo
- Publication number
- UY36396A UY36396A UY0001036396A UY36396A UY36396A UY 36396 A UY36396 A UY 36396A UY 0001036396 A UY0001036396 A UY 0001036396A UY 36396 A UY36396 A UY 36396A UY 36396 A UY36396 A UY 36396A
- Authority
- UY
- Uruguay
- Prior art keywords
- copanlisib
- diclorhydrate
- synthesis
- salt
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D233/24—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pyridine Compounds (AREA)
- Catalysts (AREA)
Abstract
La presente invención se relaciona con un nuevo método para preparar copanlisib, y diclorhidrato de copanlisib, con nuevos compuestos intermediarios, y con el uso de dichos nuevos compuestos intermediarios para la preparación de copanlisib.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14192202.1A EP3018131A1 (en) | 2014-11-07 | 2014-11-07 | Synthesis of copanlisib and its dihydrochloride salt |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY36396A true UY36396A (es) | 2016-06-30 |
Family
ID=51866060
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY0001036396A UY36396A (es) | 2014-11-07 | 2015-11-06 | Síntesis de copanlisib y su sal diclorhidrato |
Country Status (34)
| Country | Link |
|---|---|
| US (1) | US10035803B2 (es) |
| EP (2) | EP3018131A1 (es) |
| JP (1) | JP6691114B2 (es) |
| KR (1) | KR102562286B1 (es) |
| CN (1) | CN107074776B (es) |
| AR (1) | AR102568A1 (es) |
| AU (1) | AU2015341779B2 (es) |
| BR (1) | BR112017009471B1 (es) |
| CA (1) | CA2966796C (es) |
| CL (1) | CL2017001130A1 (es) |
| CO (1) | CO2017004533A2 (es) |
| DK (1) | DK3215507T3 (es) |
| EA (1) | EA031248B1 (es) |
| ES (1) | ES2716730T3 (es) |
| HR (1) | HRP20190527T8 (es) |
| HU (1) | HUE042794T2 (es) |
| IL (1) | IL251586B (es) |
| JO (1) | JO3487B1 (es) |
| LT (1) | LT3215507T (es) |
| MX (1) | MX365111B (es) |
| MY (1) | MY183123A (es) |
| NZ (1) | NZ730843A (es) |
| PE (1) | PE20170951A1 (es) |
| PL (1) | PL3215507T3 (es) |
| PT (1) | PT3215507T (es) |
| RS (1) | RS58494B1 (es) |
| SG (1) | SG11201702999XA (es) |
| SI (1) | SI3215507T1 (es) |
| TR (1) | TR201904346T4 (es) |
| TW (1) | TWI697494B (es) |
| UA (1) | UA118999C2 (es) |
| UY (1) | UY36396A (es) |
| WO (1) | WO2016071426A1 (es) |
| ZA (1) | ZA201703866B (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2168583A1 (en) | 2008-09-24 | 2010-03-31 | Bayer Schering Pharma Aktiengesellschaft | Use of substituted 2,3-dihydroimidazo[1,2-c]quinazolines for the treatment of myeloma |
| EP2508525A1 (en) | 2011-04-05 | 2012-10-10 | Bayer Pharma Aktiengesellschaft | Substituted 2,3-dihydroimidazo[1,2-c]quinazoline salts |
| SG11201507265XA (en) | 2013-04-08 | 2015-10-29 | Bayer Pharma Aktiengesllschaft | Use of substituted 2,3-dihydroimidazo[1,2-c]quinazolines for treating lymphomas |
| EP3018127A1 (en) * | 2014-11-07 | 2016-05-11 | Bayer Pharma Aktiengesellschaft | Synthesis of copanlisib and its dihydrochloride salt |
| MX2017011635A (es) | 2015-03-09 | 2018-02-09 | Bayer Pharma AG | Combinaciones que contienen 2,3-dihidroimidazo[1,2-c]quinazolina sustituida. |
| CN105130998B (zh) * | 2015-09-25 | 2017-07-28 | 苏州立新制药有限公司 | 库潘尼西的制备方法 |
| WO2017153220A1 (en) | 2016-03-08 | 2017-09-14 | Bayer Pharma Aktiengesellschaft | 2—amino—n— [7—methoxy—2, 3-dihydroimidazo-[1, 2-c] quinazolin-5-yl] pyrimidine—5—carboxamides |
| US10925880B2 (en) | 2016-09-23 | 2021-02-23 | Bayer Pharma Aktiengesellschaft | Combination of PI3K-inhibitors |
| US11185549B2 (en) | 2017-06-28 | 2021-11-30 | Bayer Consumer Care Ag | Combination of a PI3K-inhibitor with an androgen receptor antagonist |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1319674B1 (it) * | 2000-12-01 | 2003-10-23 | Erregierre Spa | Processo per la preparazione dell'acido1-(aminometil)cicloesanacetico. |
| TW565582B (en) * | 2001-04-13 | 2003-12-11 | Kaneka Corp | Diamine, acid dianhydride, and reactive group containing polyimide composition prepared therefrom and preparing them |
| ATE316085T1 (de) * | 2001-08-15 | 2006-02-15 | Du Pont | Mit heterocyclen ortho-substituierte aryl amide zur bekämpfung wirbelloser schädlinge |
| ES2367141T3 (es) | 2002-09-30 | 2011-10-28 | Bayer Pharma Aktiengesellschaft | Derivados de azol-pirimidina condensados. |
| AR064106A1 (es) * | 2006-12-05 | 2009-03-11 | Bayer Schering Pharma Ag | Derivados de 2,3-dihidroimidazo [1,2-c] quinazolina sustituida utiles para el tratamiento de enfermedades y trastornos hiper-proliferativos asociados con la angiogenesis |
| CA2713388C (en) * | 2008-01-14 | 2016-03-29 | William Scott | Sulfone substituted 2,3-dihydroimidazo [1,2-c] quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| MY156209A (en) | 2009-11-04 | 2016-01-29 | Novartis Ag | Heterocyclic sulfonamide derivatives useful mek inhibitors |
| EP2508525A1 (en) | 2011-04-05 | 2012-10-10 | Bayer Pharma Aktiengesellschaft | Substituted 2,3-dihydroimidazo[1,2-c]quinazoline salts |
-
2014
- 2014-11-07 EP EP14192202.1A patent/EP3018131A1/en not_active Withdrawn
-
2015
- 2015-05-11 UA UAA201705431A patent/UA118999C2/uk unknown
- 2015-11-03 JO JOP/2015/0273A patent/JO3487B1/ar active
- 2015-11-05 LT LTEP15790141.4T patent/LT3215507T/lt unknown
- 2015-11-05 TR TR2019/04346T patent/TR201904346T4/tr unknown
- 2015-11-05 PL PL15790141T patent/PL3215507T3/pl unknown
- 2015-11-05 EA EA201790982A patent/EA031248B1/ru not_active IP Right Cessation
- 2015-11-05 DK DK15790141.4T patent/DK3215507T3/en active
- 2015-11-05 SG SG11201702999XA patent/SG11201702999XA/en unknown
- 2015-11-05 PE PE2017000848A patent/PE20170951A1/es unknown
- 2015-11-05 MX MX2017005891A patent/MX365111B/es active IP Right Grant
- 2015-11-05 AU AU2015341779A patent/AU2015341779B2/en active Active
- 2015-11-05 CA CA2966796A patent/CA2966796C/en active Active
- 2015-11-05 CN CN201580059995.1A patent/CN107074776B/zh active Active
- 2015-11-05 PT PT15790141T patent/PT3215507T/pt unknown
- 2015-11-05 NZ NZ730843A patent/NZ730843A/en unknown
- 2015-11-05 EP EP15790141.4A patent/EP3215507B1/en active Active
- 2015-11-05 KR KR1020177011704A patent/KR102562286B1/ko active IP Right Grant
- 2015-11-05 MY MYPI2017701571A patent/MY183123A/en unknown
- 2015-11-05 US US15/524,478 patent/US10035803B2/en active Active
- 2015-11-05 BR BR112017009471-1A patent/BR112017009471B1/pt active IP Right Grant
- 2015-11-05 JP JP2017523873A patent/JP6691114B2/ja active Active
- 2015-11-05 WO PCT/EP2015/075765 patent/WO2016071426A1/en active Application Filing
- 2015-11-05 RS RS20190398A patent/RS58494B1/sr unknown
- 2015-11-05 SI SI201530660T patent/SI3215507T1/sl unknown
- 2015-11-05 HU HUE15790141A patent/HUE042794T2/hu unknown
- 2015-11-05 ES ES15790141T patent/ES2716730T3/es active Active
- 2015-11-06 TW TW104136727A patent/TWI697494B/zh active
- 2015-11-06 UY UY0001036396A patent/UY36396A/es not_active Application Discontinuation
- 2015-11-06 AR ARP150103617A patent/AR102568A1/es unknown
-
2017
- 2017-04-05 IL IL251586A patent/IL251586B/en active IP Right Grant
- 2017-05-05 CO CONC2017/0004533A patent/CO2017004533A2/es unknown
- 2017-05-05 CL CL2017001130A patent/CL2017001130A1/es unknown
- 2017-06-06 ZA ZA2017/03866A patent/ZA201703866B/en unknown
-
2019
- 2019-03-18 HR HRP20190527TT patent/HRP20190527T8/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP17027755A (es) | Síntesis de copanlisib y su sal diclorhidrato | |
| UY36396A (es) | Síntesis de copanlisib y su sal diclorhidrato | |
| CL2016002455A1 (es) | Anticuerpos multiespecíficos. | |
| CL2016001871A1 (es) | Anticuerpos humanos para pd-1 | |
| BR112016025427A2 (pt) | processos de preparação de um inibidor de jak1 e formas do mesmo | |
| BR112016017402A2 (pt) | fusões anti-pcsk9~glp-1 e métodos para uso | |
| ES2897914T8 (es) | Compuestos que contienen nitrógeno, adecuados para el uso en la producción de poliuretanos | |
| DK3164414T3 (da) | Antistoffer for IL-15 | |
| BR112017003051A2 (pt) | composto, método para produção de material magnético | |
| IN2013MU00848A (es) | ||
| BR112016029510A2 (pt) | métodos para a preparação de um composto, e, composto intermediário. | |
| CO2017010143A2 (es) | Procesos para preparar fluorocetólidos | |
| BR112016022691A2 (pt) | uso de compostos heterocíclicos para controlar nematódeos. | |
| BR112017001391A2 (pt) | componentes para o fusionamento de corpos vertebrais | |
| CL2016002925A1 (es) | Procedimiento mejorado para preparar ácidos crotónicos sustituidos | |
| TH1601002321A (th) | วิธีการสำหรับการเตรียมสารสื่อกลางของไอโอโพรไมด์ (iopromide) | |
| BR112017006916A2 (pt) | uso de cantaxantina para galinhas poedeiras. | |
| GB201517945D0 (en) | Advanced search engine for construction procurement activities | |
| UY36284A (es) | Método para la preparación de imidazopiridazinas sustituidas | |
| CO7051029A2 (es) | Proceso para la preparacion de fenilpropanonas sustituidas | |
| UA31482S (uk) | Сторінка документа для виїзду за кордон | |
| UA31481S (uk) | Сторінка документа для виїзду за кордон | |
| TH1501006850A (th) | องค์ประกอบของเซนิคริไวรอคและวิธีการสำหรับการผลิตและการใช้สิ่งดังกล่าว |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 109 | Application deemed to be withdrawn |
Effective date: 20220712 |